Please select the option that best describes you:
Topics:
Rheumatology • Sjogren’s syndrome
What tools or disease activity markers do you find most useful in tracking disease activity in Sjogren's patients?
How do you incorporate quality of life or patient reported symptoms into your disease activity assessment?
Answer from: at Academic Institution
The frequency of monitoring depends on the patient’s phenotype. For example, in patients with evidence of immunologic activity at baseline, such as B-cell hyperactivity, hypocomplementemia, or cryoglobulinemia, labs should generally be repeated every 3 to 6 months, particularly if they have ac...
Sign in or Register to read more
Answer from: at Community Practice
This would vary depending on the phenotype of the patient and which systemic domains were affected at a given point in time. The only validated disease activity instrument accepted by regulatory agencies at present is the ESSDAI (Seror et al., PMID 31236580), and the patient-reported outcome (ESSPRI...